All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for CERUS CORPORATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $40,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 3

HR 9495
Department of Defense Appropriations Act, 2027
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
HR 8800
National Defense Authorization Act for Fiscal Year 2027

Lobbying activity 3

Budget/Appropriations

H.R.9495/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.9260/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

Defense

H.R.8800/S.____ National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.